NeuralFrame Receives SOC 2 Type II Attestation

Independent Audit Verifies NeuralFrame’s Internal Controls and Processes

NeuralFrame, Inc., a medical technology company, today announced that it has completed its SOC 2 Type II audit, performed by KirkpatrickPrice. This attestation provides evidence that NeuralFrame has a strong commitment to security and to delivering high-quality services to its clients by demonstrating that they have the necessary internal controls and processes in place.

A SOC 2 audit provides an independent, third-party validation that a service organization’s information security practices meet industry standards stipulated by the AICPA. During the audit, NeuralFrame’s non-financial reporting controls as they relate to security, processing integrity, and confidentiality were tested. The SOC 2 report delivered by KirkpatrickPrice verifies the suitability of the design and operating effectiveness of NeuralFrame’s controls to meet the standards for these criteria.

“NeuralFrame employs leading-edge technology and best practices to protect patient privacy and provide state-of-the-art security.  Cancer patients deserve nothing less,” said Brian Scanlan, NeuralFrame CEO.  “Our oncology data management software, KACI® (Knowledge Assistant for Clinical Information), not only provides efficiency and productivity improvement opportunities, but it also meets the rigorous security standards stipulated by the AICPA.”

“The SOC 2 audit is based on the Trust Services Criteria,” said Joseph Kirkpatrick, President of KirkpatrickPrice. “NeuralFrame delivers trust-based services to their clients, and by communicating the results of this audit, their clients can be assured of their reliance on NeuralFrame’s controls.”


Category: News

Return to News